The association between corticosteroid treatment and gastric ulcer healing is controversial. The effects ofcorticosteroids on experimental ulcer healing in the rat were studied and the effect of coadministration of a prostaglandin E1 analogue was determined. Forty male adult rats were divided into five groups and pretreated for 10 days as follows: (a) control, (b) prednisolone (10 mg/kg), (c) prednisolone and misoprostol (300 pug(kg), (d) misoprostol, and (e) indomethacin (2 mg/lkg) Gastric ulcer was induced by applying a cryoprobe to the serosal surface of the stomach. Healing was assessed by determining the ulcer size at three and six days. (Gut 1995; 37: 613-616) 
Mucosal regenerative activity at the ulcer edge was assessed by quantitating DNA synthesis in cells by inumunohistochemical techniques using monoclonal antibodies to detect expression of proliferating cell nuclear antigen (PCNA) and incorporated 5-bromo-5-iododeoxyuridine (BrdU) . Compared with control rats, the rate of healing and the mucosal regenerative activity were significantly reduced in rats treated with prednisolone and indomethacin (p<0.05). Coadministration ofmisoprostol and corticosteroids reversed the delay in healing and the reduction in mucosal regeneration induced by corticosteroids alone. With misoprostol alone, the ulcer size and the number of epithelial cells that actively synthesised DNA did not differ from control mals. A comparison between the two immunohistochemical markers of cell proliferation showed a highly significant correlation between the two techniques (r=0.64, p<0005), indicating that the simpler PCNA technique should prove valuable in assessing regeneration in experimental ulcer disease. (Gut 1995; 37: [613] [614] [615] [616] Keywords: corticosteroids, gastric ulceration, NSAID, cell proliferation, prostaglandins, regeneration.
The interaction between adrenocorticosteroid treatment and clinical manifestations of ulcer disease in man is controversial. In a classic analysis of prospective studies of adrenocorticosteroid and adrenocorticotrophic hormone therapy, Conn and Blitzer1 concluded that overall the frequency ofpeptic ulcer was not noticeably increased during therapy, although upper gastrointestinal haemorrhage was more common in patients taking corticosteroids. In addition, peptic ulcer appeared to be more common in patients who had received a large total dose of prednisolone (>1000 mg) and those who had been treated for more than 30 days. More recently, Messer et al 2 re-examined the association between corticosteroid therapy and peptic ulceration or gastrointestinal haemorrhage in 71 controlled clinical trials. They concluded that there was an increased risk of peptic ulceration (relative risk 2.3, 95% confident interval 1.4, 3.7) and haemorrhage in patients taking corticosteroids.
These observations result in hypotheses about the mechanism of the increased incidence and complication rates of peptic ulcers and also call for strategies to TREATMENT GROUPS Animals were divided into five groups of eight. They were treated daily at 9.30 am starting 10 days before ulcer induction and continuing until they were killed. The groups were treated as follows: * Group A: phosphate buffer (pH 7.4) by gavage, and sodium bicarbonate (5%) by subcutaneous injection (controls); * Group B: indomethacin (2 mg/kg) by subcutaneous injection and gavage vehicle; * Group C: prednisolone (10 mg/kg) by subcutaneous injection and gavage vehicle; * Group D: prednisolone (10 mg/kg) by subcutaneous injection and misoprostol (300 ,ug/kg) by gavage; * Group E: misoprostol (300 ,ug/kg) by gavage and sodium carbonate by subcutaneous injection. The dosages of indomethacin and the PGE1 analogue were those given in the study of Levi et al. 3 The level of indomethacin was that which would inhibit repair without inducing gastric mucosal ulceration and the misoprostol was given in a dose which would reverse this effect. Prednisolone was given in a dosage shown to modulate ribosomal RNA synthesis in rats.4
On days 3 and 6 after ulcer induction, four animals from each group were given an intraperitoneal injection of BrdU (100 ,ug/g body weight). They were killed an hour later for determination of ulcer size and proliferation activity assessment at ulcer edges.
ULCER INDUCTION
Ulcers were induced as described3 5 in unfasted rats after laparotomy performed under anaesthesia by intramuscular injection of 1 ml/kg Hypnorm (fentanyl citrate 0X315 mg/ml, fluanisone 10 mg/ml, Janssen Pharmaceuticals) at 9.00 am. The cryoprobe was cooled to equilibrium in liquid nitrogen and then applied to the serosal surface of the anterior wall of the stomach for 45 seconds at two different sites 8 mm apart. After recovery animals were allowed free access to rat chow and water.
ULCER SIZE ASSESSMENT
After death the rat's stomach was opened and the ulcer size was determined in the pinned out stomach by square counting under a dissecting microscope. ASSESSMENT an alteration in the proliferative response to injury. The study reported here shows that the delay in healing induced by corticosteroids involved a diminution in the processes of cell proliferation that causes regenerative repair at the ulcer edge, with a reduction in DNA synthesis in the proliferative zone of gastric crypts adjacent to the ulcers.
The mechanisms by which corticosteroids affect gastric cell proliferation are not fully understood but an effect via prostaglandin metabolism seems likely. Corticosteroids inhibit phospholipase A2, which influences the liberation of arachidonic acid, the first step in the generation of prostaglandins. Corticosteroids also stimulate the production of a number of proteins that inhibit prostanoid action, such as lipocortin.'0 11 Eastwood et al showed an inhibitory effect of hydrocortisone sodium succinate on prostaglandin generation in the rat fundic mucosa.12 Exogenous PGE2 and PGE, reversed the effects of hydrocortisone in delaying in healing of acetic acid induced ulcers.7 Our results show that PGE, reversed the effect of prednisone on cryoulcers, and, in terms of regenerative repair, the effect of the corticosteroid on ulcer healing is similar to that of the prostaglandin synthetase inhibitor indomethacin.
In addition to effects on regenerative repair, inhibition of prostaglandin synthesis by corticosteroids will have an effect on a number of other prostaglandin mediated defence mechanisms: thickening of gastric mucus, stimulation of active bicarbonate secretion, changes in vascular supply, acid inhibition, increased flux of water from the serosa to the mucosa, and possibly inhibition of adhesion of neutrophils to blood vessels.13
Many of these prostaglandin mediated cytoprotective effects and the inhibitory effects of corticosteroids on prostanoids have been demonstrated more readily in animals than man, and the relevance that each of these effects has to ulcer healing in the clinical situation remains unclear. With regard to the dose of corticosteroid used in our study, and in similar experiments,6 7 this is higher than that normally used long term treatment (0 1-1 mg/kg) but similar to that used short term in conditions such as graft rejection (10-15 mg/kg). As already mentioned, the clinical association between corticosteroid therapy and peptic ulcer is best established at higher dosage. I In this study we compared immunostaining for incorporated BrdU with staining for PCNA. Antibodies to PCNA have proved to be effective in quantitatively assessing nuclear labelling in a variety of tissues including the colon and the liver; this study shows their value in quantitating cell proliferation in rat gastric mucosa and confirms that the technique provides similar results to those obtained with BRDU staining after in vivo labelling.'4 15 The technical advantages of the PCNA technique, giving spatial and quantitative assessment of proliferation as does the BrdU technique, but without in vivo injections of label, and with the advantages of applicability to paraffin embedded tissue, make this a highly suitable marker for assessing regeneration in experimental ulcer disease. '6 17 epithelium in experimental gastric ulcers.
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